Calcium channel

Results: 307



#Item
211Maine State Maximum Allowable Cost List as of[removed]FORM CURRENT MAC PRICE

Maine State Maximum Allowable Cost List as of[removed]FORM CURRENT MAC PRICE

Add to Reading List

Source URL: www.mainecarepdl.org

Language: English - Date: 2014-07-11 09:52:14
212Effective[removed]Alphabetical by Brand Name (when applicable) Medical Assistance Handbook  Prior Authorization of Pharmaceutical Services

Effective[removed]Alphabetical by Brand Name (when applicable) Medical Assistance Handbook Prior Authorization of Pharmaceutical Services

Add to Reading List

Source URL: www.dpw.state.pa.us

Language: English - Date: 2014-08-14 15:11:21
213CALAN® verapamil hydrochloride tablets DESCRIPTION CALAN (verapamil HCl) is a calcium ion influx inhibitor (slow-channel blocker or calcium ion antagonist) available for oral administration in film-coated tablets contai

CALAN® verapamil hydrochloride tablets DESCRIPTION CALAN (verapamil HCl) is a calcium ion influx inhibitor (slow-channel blocker or calcium ion antagonist) available for oral administration in film-coated tablets contai

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2011-06-30 14:50:25
214doi:[removed]j.cell[removed]

doi:[removed]j.cell[removed]

Add to Reading List

Source URL: www.sads.ca

Language: English - Date: 2013-03-19 11:00:43
215BCPharmaCare Newsletter   August 6, 2009 Edition[removed]Published by the Pharmaceutical Services Division to provide information for British Columbia’s health care providers 

BCPharmaCare Newsletter   August 6, 2009 Edition[removed]Published by the Pharmaceutical Services Division to provide information for British Columbia’s health care providers 

Add to Reading List

Source URL: www.health.gov.bc.ca

Language: English - Date: 2014-03-05 12:00:05
216NDA[removed]S-021 Page 3 CALAN - verapamil hydrochloride tablet, film coated G.D. Searle LLC[removed]CALAN®

NDA[removed]S-021 Page 3 CALAN - verapamil hydrochloride tablet, film coated G.D. Searle LLC[removed]CALAN®

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2009-07-23 20:35:24
217Bulletin # 865  June 26, 2013 NBPDP Formulary Update Please find attached a list of interchangeable product additions to the New Brunswick

Bulletin # 865 June 26, 2013 NBPDP Formulary Update Please find attached a list of interchangeable product additions to the New Brunswick

Add to Reading List

Source URL: www.gnb.ca

Language: English - Date: 2013-06-26 11:12:05
218BC PharmaCare Newsletter[removed]

BC PharmaCare Newsletter[removed]

Add to Reading List

Source URL: www.health.gov.bc.ca

Language: English - Date: 2014-03-05 12:00:05
219Cardene® I.V. Premixed Injection (0.1 mg/mL) in either 4.8% Dextrose or 0.86% Sodium Chloride Rx Only HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Cardene I.V.

Cardene® I.V. Premixed Injection (0.1 mg/mL) in either 4.8% Dextrose or 0.86% Sodium Chloride Rx Only HIGHLIGHTS OF PRESCRIBING INFORMATION These highlights do not include all the information needed to use Cardene I.V.

Add to Reading List

Source URL: www.accessdata.fda.gov

Language: English - Date: 2010-01-20 12:05:19
220Amines / Cardiac dysrhythmia / Organofluorides / Calcium channel blockers / Ethers / Torsades de pointes / Ventricular tachycardia / Mibefradil / Pimozide / Chemistry / Organic chemistry / Medicine

a1Document; a2Document; a3Document; a4Document; a5Document; a6Document; a7Document; a8Document; a1Technical; a2Technical; a3Tech

Add to Reading List

Source URL: www.fda.gov

Language: English - Date: 1998-03-12 09:31:49